ASX News
Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| QUB | News: QUB Qube Expects To Deliver Underlying NPATA And EPSA Growth In FY24 Of 10%-15% | 02/05/24 | 1 | 459 | |||
|
|||||||
| QUB | Ann: Qube Investor Day Presentation | 01/05/24 | 0 | 204 | |||
|
|||||||
| QUB | Ann: FY24 Trading Update and Outlook | 01/05/24 | 0 | 213 | |||
|
|||||||
| QUB | Ann: Half Year Investor Presentation | 30/04/24 | 5 | 1.3K | |||
|
|||||||
| QUB | Ann: Change in substantial holding | 26/04/24 | 0 | 192 | |||
|
|||||||
| QUB | Ann: Notification regarding unquoted securities - QUB | 17/04/24 | 0 | 117 | |||
|
|||||||
| QUB | Ann: Notification regarding unquoted securities - QUB | 17/04/24 | 0 | 142 | |||
|
|||||||
| QUB | Ann: Notification regarding unquoted securities - QUB | 08/04/24 | 0 | 142 | |||
|
|||||||
See All Discussions
Timeline
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
$3.59 |
Change
0.020(0.56%) |
Mkt cap ! $6.342B | |||
| Open | High | Low | Value | Volume |
| $3.62 | $3.62 | $3.57 | $13.66M | 3.806M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3382 | $3.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.60 | 52075 | 6 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$3.59 |
Change
0.020 ( 0.85 %) |
||||
| Open | High | Low | Volume | ||
| $3.61 | $3.62 | $3.57 | 611720 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| QUB (ASX) Chart |
